Literature DB >> 11291605

[Evaluation of complement component C4 concentration and immunoglobulins IgA, IgG, and IgM in serum of patients with primary essential hypertension].

M Tomaszewski1, E Zukowska-Szczechowska, W Grzeszczak.   

Abstract

The aim of the study was to determine serum concentration of complement component C4 and IgA, IgG, IgM immunoglobulins in hypertensive patients and healthy controls as well as to assess the interrelationships regarding some immunological and clinical data in the study group. The study group consisted of 81 hypertensive patients (with secondary forms of hypertension excluded), 44 females and 37 males (mean age 51.2 +/- 14.5 years). The control group comprised 34 healthy volunteers, 19 females and 15 males (mean age 47.5 +/- 15.3 years). C4, IgA, IgG, IgM serum concentrations were evaluated with turbidymetry. C4 serum concentration was significantly higher in hypertensive patients when compared to the controls. No significant differences in IgA, IgG, IgM serum concentrations existed between the groups. The duration of hypertension correlated positively with C4 serum concentration. Elevated C4 serum concentration may be one of the markers of immunological disturbances existing in hypertensive patients. IgA, IgG, IgM immunoglobulins do not seem to be directly associated with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11291605

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  3 in total

Review 1.  The immune system and hypertension.

Authors:  Madhu V Singh; Mark W Chapleau; Sailesh C Harwani; Francois M Abboud
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

2.  CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice.

Authors:  Barbara Coles; Ruth Lewis; Peter B Anning; Jonathan Morton; Sivasankar Baalasubramanian; B Paul Morgan; Valerie B O'Donnell
Journal:  Immunology       Date:  2007-04-13       Impact factor: 7.397

3.  Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein.

Authors:  Eli Magen; Joseph Mishal; Jana Paskin; Zahava Glick; Chaim Yosefy; Mona Kidon; Menachem Schlesinger
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-09       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.